109 related articles for article (PubMed ID: 16222010)
21. Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite.
Jones TR; Obaldia N; Gramzinski RA; Hoffman SL
Am J Trop Med Hyg; 2000 Jun; 62(6):675-80. PubMed ID: 11304053
[TBL] [Abstract][Full Text] [Related]
22. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum.
Herrera S; Herrera MA; Corredor A; Rosero F; Clavijo C; Guerrero R
Am J Trop Med Hyg; 1992 Nov; 47(5):682-90. PubMed ID: 1449209
[TBL] [Abstract][Full Text] [Related]
23. Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge.
Friedman-Klabanoff DJ; Berry AA; Travassos MA; Shriver M; Cox C; Butts J; Lundeen JS; Strauss KA; Joshi S; Shrestha B; Mo AX; Nomicos EYH; Deye GA; Regules JA; Bergmann-Leitner ES; Pasetti MF; Laurens MB
J Infect Dis; 2024 Jun; 229(6):1883-1893. PubMed ID: 38330357
[TBL] [Abstract][Full Text] [Related]
24. A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.
Karen KA; Deal C; Adams RJ; Nielsen C; Ward C; Espinosa DA; Xie J; Zavala F; Ketner G
Infect Immun; 2015 Jan; 83(1):268-75. PubMed ID: 25368113
[TBL] [Abstract][Full Text] [Related]
25. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
Burghaus PA; Wellde BT; Hall T; Richards RL; Egan AF; Riley EM; Ballou WR; Holder AA
Infect Immun; 1996 Sep; 64(9):3614-9. PubMed ID: 8751907
[TBL] [Abstract][Full Text] [Related]
26. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.
Inselburg J; Bathurst IC; Kansopon J; Barr PJ; Rossan R
Infect Immun; 1993 May; 61(5):2048-52. PubMed ID: 8478093
[TBL] [Abstract][Full Text] [Related]
27. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
Lyon JA; Angov E; Fay MP; Sullivan JS; Girourd AS; Robinson SJ; Bergmann-Leitner ES; Duncan EH; Darko CA; Collins WE; Long CA; Barnwell JW
PLoS One; 2008 Jul; 3(7):e2830. PubMed ID: 18665258
[TBL] [Abstract][Full Text] [Related]
28. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
Carvalho LJ; Alves FA; Bianco C; Oliveira SG; Zanini GM; Soe S; Druilhe P; Theisen M; Muniz JA; Daniel-Ribeiro CT
Clin Diagn Lab Immunol; 2005 Feb; 12(2):242-8. PubMed ID: 15699417
[TBL] [Abstract][Full Text] [Related]
29. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
Stowers AW; Chen Lh LH; Zhang Y; Kennedy MC; Zou L; Lambert L; Rice TJ; Kaslow DC; Saul A; Long CA; Meade H; Miller LH
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):339-44. PubMed ID: 11752405
[TBL] [Abstract][Full Text] [Related]
30. Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A.
Kaba SA; Price A; Zhou Z; Sundaram V; Schnake P; Goldman IF; Lal AA; Udhayakumar V; Todd CW
Clin Vaccine Immunol; 2008 Nov; 15(11):1674-83. PubMed ID: 18784343
[TBL] [Abstract][Full Text] [Related]
31. Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice.
Rafi-Janajreh A; Tongren JE; Kensil C; Hackett C; Candal F; Lal A; Udhayakumar V
Exp Parasitol; 2002 May; 101(1):3-12. PubMed ID: 12243733
[TBL] [Abstract][Full Text] [Related]
32. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.
Collins WE; Pye D; Crewther PE; Vandenberg KL; Galland GG; Sulzer AJ; Kemp DJ; Edwards SJ; Coppel RL; Sullivan JS
Am J Trop Med Hyg; 1994 Dec; 51(6):711-9. PubMed ID: 7810803
[TBL] [Abstract][Full Text] [Related]
33. Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.
Hoffman SL; Edelman R; Bryan JP; Schneider I; Davis J; Sedegah M; Gordon D; Church P; Gross M; Silverman C
Am J Trop Med Hyg; 1994 Nov; 51(5):603-12. PubMed ID: 7985753
[TBL] [Abstract][Full Text] [Related]
34. The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Steiner-Monard V; Kamaka K; Karoui O; Roethlisberger S; Audran R; Daubenberger C; Fayet-Mello A; Erdmann-Voisin A; Felger I; Geiger K; Govender L; Houard S; Huber E; Mayor C; Mkindi C; Portevin D; Rusch S; Schmidlin S; Tiendrebeogo RW; Theisen M; Thierry AC; Vallotton L; Corradin G; Leroy O; Abdulla S; Shekalaghe S; Genton B; Spertini F; Jongo SA
Clin Infect Dis; 2019 Jan; 68(3):466-474. PubMed ID: 29945169
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and protective efficacy of Plasmodium falciparum liver-stage Ag-3 in Aotus lemurinus griseimembra monkeys.
Perlaza BL; Zapata C; Valencia AZ; Hurtado S; Quintero G; Sauzet JP; Brahimi K; Blanc C; Arévalo-Herrera M; Druilhe P; Herrera S
Eur J Immunol; 2003 May; 33(5):1321-7. PubMed ID: 12731057
[TBL] [Abstract][Full Text] [Related]
36. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.
Nardin EH; Oliveira GA; Calvo-Calle JM; Wetzel K; Maier C; Birkett AJ; Sarpotdar P; Corado ML; Thornton GB; Schmidt A
Infect Immun; 2004 Nov; 72(11):6519-27. PubMed ID: 15501783
[TBL] [Abstract][Full Text] [Related]
37. Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys.
Sullivan JS; Sullivan JJ; Williams A; Grady KK; Bounngaseng A; Huber CS; Nace D; Williams T; Galland GG; Barnwell JW; Collins WE
Am J Trop Med Hyg; 2003 Dec; 69(6):593-600. PubMed ID: 14740874
[TBL] [Abstract][Full Text] [Related]
38. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
Kashala O; Amador R; Valero MV; Moreno A; Barbosa A; Nickel B; Daubenberger CA; Guzman F; Pluschke G; Patarroyo ME
Vaccine; 2002 May; 20(17-18):2263-77. PubMed ID: 12009282
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
